(Q37649474)

21 August 2017

1 reference

title

Stereotactic body radiation therapy: a novel treatment modality (English)

1 reference

21 August 2017

0 references

Simon S Lo

1

1 reference

21 August 2017

Achilles J Fakiris

2

1 reference

21 August 2017

Eric L Chang

3

1 reference

21 August 2017

Nina A Mayr

4

1 reference

21 August 2017

Jian Z Wang

5

1 reference

21 August 2017

Lech Papiez

6

1 reference

21 August 2017

Bin S Teh

7

1 reference

21 August 2017

Ronald C McGarry

8

1 reference

21 August 2017

Higinia R Cardenes

9

1 reference

21 August 2017

Robert D Timmerman

10

1 reference

21 August 2017

language of work or name

English

0 references

publication date

8 December 2009

1 reference

Nature Reviews Clinical Oncology

21 August 2017

1 reference

21 August 2017

7

1 reference

21 August 2017

1

1 reference

21 August 2017

44-54

1 reference

Universal survival curve and single fraction equivalent dose: useful tools in understanding potency of ablative radiotherapy

21 August 2017

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2009.188

Phase I clinical evaluation of near-simultaneous computed tomographic image-guided stereotactic body radiotherapy for spinal metastases.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2009.188

Optimization of radiation therapy: integral-response of a model biological system.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2009.188

Frameless stereotactic body radiotherapy for lung cancer using four-dimensional cone beam CT guidance.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2009.188

Four-dimensional CT scans for treatment planning in stereotactic radiotherapy for stage I lung cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2009.188

Stereotactic body radiation therapy in centrally and superiorly located stage I or isolated recurrent non-small-cell lung cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2009.188

Computed tomography-guided frameless stereotactic radiotherapy for stage I non-small cell lung cancer: a 5-year experience.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2009.188

Stereotactic body frame based fractionated radiosurgery on consecutive days for primary or metastatic tumors in the lung

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2009.188

Univariate analysis of factors correlated with tumor control probability of three-dimensional conformal hypofractionated high-dose radiotherapy for small pulmonary or hepatic tumors.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2009.188

Stereotactic body radiosurgery for spinal metastases: a critical review

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2009.188

Image-guided robotic stereotactic body radiotherapy for benign spinal tumors: theUniversity of California San Francisco preliminary experience

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2009.188

Stereotactic hypofractionated accurate radiotherapy of the prostate (SHARP), 33.5 Gy in five fractions for localized disease: first clinical trial results

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2009.188

Stereotactic body radiotherapy for localized prostate cancer: interim results of a prospective phase II clinical trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2009.188

Phase I study of stereotactic radiosurgery in patients with locally advanced pancreatic cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2009.188

Phase II study to assess the efficacy of conventionally fractionated radiotherapy followed by a stereotactic radiosurgery boost in patients with locally advanced pancreatic cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2009.188

Gemcitabine chemotherapy and single-fraction stereotactic body radiotherapy for locally advanced pancreatic cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2009.188

Acute skin toxicity following stereotactic body radiation therapy for stage I non-small-cell lung cancer: who's at risk?

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2009.188

Stereotactic High Dose Fraction Radiation Therapy of Extracranial Tumors Using An Accelerator: Clinical experience of the first thirty-one patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2009.188

Stereotactic body radiation therapy

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2009.188

Focal, high dose, and fractionated modified stereotactic radiation therapy for lung carcinoma patients: a preliminary experience.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2009.188

Stereotactic body radiation therapy in multiple organ sites

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2009.188

Extracranial stereotactic radioablation: results of a phase I study in medically inoperable stage I non-small cell lung cancer.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2009.188

Excessive toxicity when treating central tumors in a phase II study of stereotactic body radiation therapy for medically inoperable early-stage lung cancer

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2009.188

Phase I Study of Individualized Stereotactic Body Radiotherapy for Hepatocellular Carcinoma and Intrahepatic Cholangiocarcinoma

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2009.188

Multi-institutional phase I/II trial of stereotactic body radiation therapy for lung metastases

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2009.188

Multi-institutional phase I/II trial of stereotactic body radiation therapy for liver metastases

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2009.188

Phase I/II study of stereotactic body radiotherapy for spinal metastasis and its pattern of failure

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2009.188

Engaging the vascular component of the tumor response

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2009.188

Tumor response to radiotherapy regulated by endothelial cell apoptosis

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2009.188

Therapeutic effects of ablative radiation on local tumor require CD8+ T cells: changing strategies for cancer treatment

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2009.188

Potential of image-guidance, gating and real-time tracking to improve accuracy in pulmonary stereotactic body radiotherapy.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2009.188

Stereotactic body radiation therapy: a comprehensive review

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2009.188

Stereotactic body radiation therapy for nonpulmonary primary tumors

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2009.188

Stereotactic body radiation therapy for oligometastases

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2009.188

Stereotactic body radiation therapy for early-stage non-small-cell lung cancer

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2009.188

Stereotactic body radiation therapy of early-stage non-small-cell lung carcinoma: phase I study

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2009.188

Stereotactic body radiation therapy for early-stage non-small-cell lung carcinoma: four-year results of a prospective phase II study

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2009.188

Clinical outcomes of a phase I/II study of 48 Gy of stereotactic body radiotherapy in 4 fractions for primary lung cancer using a stereotactic body frame

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2009.188

Outcome in a prospective phase II trial of medically inoperable stage I non-small-cell lung cancer patients treated with stereotactic body radiotherapy

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2009.188

A radiographic and tomographic imaging system integrated into a medical linear accelerator for localization of bone and soft-tissue targets

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2009.188

Stereotactic single-dose radiotherapy (radiosurgery) of early stage nonsmall-cell lung cancer (NSCLC).

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2009.188

Stereotactic hypofractionated radiotherapy for stage I non-small cell lung cancer--mature results for medically inoperable patients

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2009.188

Stereotactic hypofractionated high-dose irradiation for stage I nonsmall cell lung carcinoma: clinical outcomes in 245 subjects in a Japanese multiinstitutional study

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2009.188

Stereotactic hypofractionated radiotherapy in stage I (T1-2 N0 M0) non-small-cell lung cancer (NSCLC).

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2009.188

Clinical outcomes of 3D conformal hypofractionated single high-dose radiotherapy for one or two lung tumors using a stereotactic body frame

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2009.188

Escalated Focal Liver Radiation and Concurrent Hepatic Artery Fluorodeoxyuridine for Unresectable Intrahepatic Malignancies

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2009.188

Stereotactic radiotherapy of primary liver cancer and hepatic metastases

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2009.188

Fractionated stereotactic radiotherapy in patients with primary hepatocellular carcinoma

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2009.188

Stereotactic body radiation therapy for primary and metastatic liver tumors: A single institution phase i-ii study

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2009.188

Extracranial radiosurgery (stereotactic body radiation therapy) for oligometastases

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2009.188

Megavoltage CT-assisted stereotactic radiosurgery for thoracic tumors: original research in the treatment of thoracic neoplasms

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2009.188

Stereotactic radiotherapy of targets in the lung and liver

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2009.188

Stereotactic radiotherapy for primary lung cancer and pulmonary metastases: a noninvasive treatment approach in medically inoperable patients

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2009.188

Stereotactic single high dose irradiation of lung tumors under respiratory gating.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2009.188

Stereotactic single-dose radiotherapy of lung metastases

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2009.188

Stereotactic Body Radiation Therapy (SBRT) for lung metastases

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2009.188

Stereotactic body radiotherapy for oligometastatic lung tumors

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2009.188

Dose-response relationship for image-guided stereotactic body radiotherapy of pulmonary tumors: relevance of 4D dose calculation

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2009.188

Hypofractionated stereotactic radiotherapy for primary and secondary intrapulmonary tumors: first results of a phase I/II study

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2009.188

Hypofractionated stereotactic body radiation therapy (SBRT) for limited hepatic metastases

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2009.188

Curative stereotactic body radiotherapy for liver malignancy

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2009.188

Stereotactic single-dose radiation therapy of liver tumors: results of a phase I/II trial.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2009.188

Phase I study of individualized stereotactic body radiotherapy of liver metastases.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2009.188

Stereotactic radiosurgery and radiation therapy for spinal tumors

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2009.188

Image-guided and intensity-modulated radiosurgery for patients with spinal metastasis

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2009.188

Postoperative radiosurgery for malignant spinal tumors.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2009.188

Stereotactic radiosurgery for spinal metastases from renal cell carcinoma

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2009.188

Radiosurgery for spinal metastases: clinical experience in 500 cases from a single institution.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2009.188

Radiosurgery for the treatment of spinal melanoma metastases

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2009.188

Single-fraction radiosurgery for the treatment of spinal breast metastases

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2009.188

Combination kyphoplasty and spinal radiosurgery: a new treatment paradigm for pathological fractures.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2009.188

Image-guided robotic radiosurgery for spinal metastases.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2009.188

Multifractionated image-guided and stereotactic intensity-modulated radiotherapy of paraspinal tumors: A preliminary report

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2009.188

High-dose, single-fraction image-guided intensity-modulated radiotherapy for metastatic spinal lesions

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2009.188

Radiosurgery for benign intradural spinal tumors

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2009.188

CyberKnife radiosurgery for benign intradural extramedullary spinal tumors

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2009.188

Renal radiosurgery: initial clinical experience with histological evaluation

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2009.188

Definitive, high-dose-per-fraction, conformal, stereotactic external radiation for renal cell carcinoma

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2009.188

Extracranial stereotactic radiotherapy for primary and metastatic renal cell carcinoma

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2009.188

A prospective Phase II trial of using extracranial stereotactic radiotherapy in primary and metastatic renal cell carcinoma

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2009.188

Phase-II study on stereotactic radiotherapy of locally advanced pancreatic carcinoma

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2009.188

Radiation pneumonitis in patients treated for malignant pulmonary lesions with hypofractionated radiation therapy

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2009.188

Chest wall volume receiving >30 Gy predicts risk of severe pain and/or rib fracture after lung stereotactic body radiotherapy

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2009.188

Radiation-induced rib fractures after hypofractionated stereotactic body radiation therapy of non-small cell lung cancer: a dose- and volume-response analysis.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2009.188

Brachial plexopathy from stereotactic body radiotherapy in early-stage NSCLC: dose-limiting toxicity in apical tumor sites.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2009.188

The Norton-Simon hypothesis revisited

31 March 2020

1 reference

12 December 2020

Results of a phase I dose-escalation study using single-fraction stereotactic radiotherapy for lung tumors

1 reference

12 December 2020

Survival results among patients with alpha-fetoprotein-positive, unresectable hepatocellular carcinoma: analysis of three sequential treatments of the RTOG and Johns Hopkins Oncology Center.

1 reference

12 December 2020

Patterns of failure after single-dose radiosurgery for spinal metastasis

1 reference

12 December 2020

10.1038/NRCLINONC.2009.188

Identifiers

DOI

1 reference

21 August 2017

1 reference